XTalks

APRIL 21, 2023

The application of whole genome sequencing (WGS) to derive a more complete understanding of cancer has been a central goal of cancer researchers even before the first human genome was decoded in 2003. Ultima Genomics has already partnered with other leading biotech startups.

Genomics 97

Genomics Genome Bioinformatics Genetics 97

pharmaphorum

SEPTEMBER 14, 2020

Here he gives us a deeper look at how genomic medicine is evolving and the barriers that are preventing it from reaching its full potential. I saw this, in particular, with the finishing of the human genome,” says Charlie. “At In reality, finishing the human genome was the first step of what is a long journey.”.

Genomics 119

Genomics Genome Medicine Gene 119

Pharmaceutical Technology

JUNE 30, 2022

Earlier this month, scientists from Cambridge University and the Madrid-based National Cancer Research Center described a novel framework tracking chromosomal instability and copy number changes in particularly deadly cancers. Genomic research have greatly expanded our understanding of disease pathophysiology over the years.

Genome Project 130

Genome Project Genomics Genome DNA 130

Pharmaceutical Technology

JULY 26, 2022

The last few months have marked the publication of research emerging from projects designed to collect and analyse genomic data on a wider scale than was previously thought possible. The post Magazine: Genomic projects exploit scale as clinical applications play catch-up appeared first on Pharmaceutical Technology.

Genome Project 130

Genome Project Genomics Genome Clinical Trials 130

BioSpace

AUGUST 30, 2020

When Bionano Genomics acquired Lineagen, Inc. in August, the genomic analysis company gained the final piece it needed to provide comprehensive structural variation detection for researchers and drug developers and a reimbursement pathway for clinicians who want to use its technology to replace c.

Genome 121

Genome Genomics Development Drugs 121

AuroBlog - Aurous Healthcare Clinical Trials blog

MAY 30, 2024

Our latest research suggests that some ancient viral DNA sequences in the […] These sequences, known as human endogenous retroviruses (or Hervs), date back hundreds of thousands to millions of years – with some even predating the emergence of Homo sapiens.

DNA 181

DNA Genomics Genome Genetics 181

pharmaphorum

OCTOBER 12, 2022

David Del Bourgo (CEO and co-founder, Whitelab Genomics) has always been passionate about introducing disruptive, innovative technologies to markets. We founded Whitelab Genomics after realising the potential to use data, data science, and AI in a more systematic way to develop genomic therapies,” Del Bourgo says.

Genome 105

Genome Genomics Medicine Development 105

pharmaphorum

OCTOBER 31, 2022

Verge Genomics has joined a select group of biotechs who have taken a drug discovered and developed using artificial intelligence into human testing. The post Verge Genomics takes AI-sourced drug for ALS into clinic appeared first on.

Genomics 136

Genomics Genome Drugs RNA 136

Pharmaceutical Technology

FEBRUARY 13, 2023

While several therapeutics are available for treating symptoms associated with epilepsy, researchers and patients have strongly called out the need for more holistic treatments that would address the condition as a whole. Meanwhile, others are researching the link between gene variation and different responses to treatments.

Research 264

Research Gene Gene Therapy Genomics 264

Pharma Times

JULY 2, 2024

Affecting around 3,755 young people in the UK every year, leukaemia is the most commonly diagnosed cancer in children

Genomics 131

Genomics Genome Research 131

pharmaphorum

NOVEMBER 27, 2022

A group representing pharma companies selling precision therapies for cancer has called for a change to the way genomic testing is done in Scotland, to make sure patients get access to targeted drugs. The post Genomic testing ‘should be offered to all cancer patients in Scotland’ appeared first on. Why not lead?”

Genomics 104

Genomics Genome Genetics Medicine 104

Medical Xpress

NOVEMBER 7, 2022

Tailoring the analysis of whole genome sequencing to individual patients could double the diagnostic rates of rare diseases, finds a new study led by UCL researchers.

Genome 98

Genome Genomics Research 98

pharmaphorum

SEPTEMBER 12, 2022

Alongside drugs and therapeutics, data collection and technology enhancements have redefined the traditional healthcare experience, especially within oncology, and genomic profiling has become a significant factor in allowing for personalised care. Tailored oncology.

Genomics 105

Genomics Genome Clinical Trials Clinical Trials 105

STAT News

APRIL 12, 2023

LONDON — Using genome sequencing greatly expanded the number of diagnoses researchers could provide for children with developmental disorders from thousands of families across the United Kingdom and Ireland, researchers reported in a new study Wednesday. Read the rest…

Genomics 98

Genomics Genome Medicine Research 98

Medical Xpress

DECEMBER 13, 2022

UK health authorities on Tuesday announced a pioneering research programme using the genomes of 100,000 new-born babies, to detect rare genetic illnesses and speed up treatment.

Genome 96

Genome Genomics Genetics Research 96

Scienmag

JUNE 26, 2022

June 27, 2022–The first high-quality genome of the desert locust—those voracious feeders of plague and devastation infamy and the most destructive migratory insect in the world—has been produced by U.S. Department of Agriculture Agricultural Research Service scientists. Credit: Photo by Brandon Woo.

Genomics 89

Genomics Genome Scientist Research 89

STAT News

AUGUST 17, 2022

When the Smithsonian National Museum of Natural History opened its genomics exhibit in 2013, the field was just celebrating the 10th anniversary of the completed Human Genome Project. Sequencing that first genome cost over $500 million. The genomes since cost $10,000. The development of CRISPR-Cas9 landed a Nobel Prize.

Genomics 98

Genomics Genome Genome Project DNA 98

Pharma Times

DECEMBER 22, 2022

Vital financing will help boost diagnosis, treatment and prospects of patient groups

Genomics 129

Genomics Genome Research 129

Scienmag

JULY 13, 2022

LAWRENCE — A comprehensive new genetic and statistical study from researchers at the University of Kansas reveals two groups of scrub jays — one in Mexico and one in Texas — deserve status as independent species.

Genomics 84

Genomics Genome Research Genetics 84

STAT News

AUGUST 11, 2022

The company would begin sequencing and analyzing the DNA of 150,000 people from Mexico City, thanks to a research collaboration with the University of Oxford. As the only Mexican geneticist at Regeneron, Gonzaga saw this as a unique opportunity.

Genomics 105

Genomics Genome Research DNA 105

STAT News

MARCH 6, 2023

That was the message Chinese scientists delivered Monday on the opening day of the Third International Summit on Human Genome Editing in London. LONDON — The first gene-edited children were born in China five years ago , but it’s unlikely to happen again there anytime soon. Continue to STAT+ to read the full story…

Genomics 98

Genomics Genome Gene Editing Genetics 98

STAT News

MARCH 3, 2023

Next week, hundreds of scientists from around the world will convene in London for an international summit on genome editing. That technology, which enables scientists to easily excise, alter, or replace specific sections of DNA, was awarded the 2020 Nobel Prize for Chemistry. Continue to STAT+ to read the full story…

Genomics 111

Genomics Genome Gene Editing Genetic Disease 111

Pharmaceutical Technology

NOVEMBER 5, 2024

This initiative brings together UK Biobank, Genomics England, NHS England, and Oxford Nanopore to accelerate genomics-based research in the UK.

Biobanking 147

Biobanking Genomics Genome Development 147

Medical Xpress

APRIL 14, 2023

The Hereditary Cancer research group from the Germans Trias i Pujol Research Institute (IGTP) has led an international collaboration that has allowed the genomic characterization of the most commonly used cell lines derived from malignant peripheral nerve sheath tumors (MPNSTs).

Genomics 96

Genomics Genome Research 96

Pharmaceutical Technology

SEPTEMBER 12, 2023

The biotech received $72m in a Series B extension round from Big Pharma to invest in autoimmune disease research.

Genomics 162

Genomics Genome Research 162

Medical Xpress

MAY 4, 2023

Researchers at Karolinska Institutet and Karolinska University Hospital have together with health economists at Linköping University analyzed costs for various methods to diagnose genetic causes of intellectual disability.

Genomics 98

Genomics Genome Genetics Research 98

Medical Xpress

APRIL 4, 2023

Prostate cancer tumors harboring BRCA1/2 mutations are exceptionally sensitive to PARP inhibitors, while genomic alterations in other DNA damage response (DDR) genes are less responsive.

Genomics 92

Genomics Genome DNA Gene 92

STAT News

DECEMBER 12, 2022

LONDON — England is launching a pilot program sequencing the genomes of up to 100,000 newborns to see if such a strategy can speed up the detection of genetic illnesses. The Newborn Genomes Programme will scan DNA for mutations that can cause some 200 conditions.

Genomics 98

Genomics Genome Genetic Disease Genetics 98

Pharma Times

AUGUST 19, 2024

In the UK study, researchers analysed 2,023 bowel cancers from the 100,000 Genomes Project

Genome Project 118

Genome Project Genetics Research Genomics 118

AuroBlog - Aurous Healthcare Clinical Trials blog

NOVEMBER 1, 2022

As drug companies have embarked on an initiative to launch affordable medicines for rare diseases in India, experts have called for using pharmacogenetics to develop treatments and whole genome sequencing to identify etiologies. There […].

Development 189

Development Genomics Genome Medicine 189

STAT News

MARCH 22, 2023

Stanford cardiologist Euan Ashley and his research team received a Guinness World Record last year for sequencing a full human genome in just over five hours. Ashley is at the forefront of a push by researchers to make more genetic information available to patients facing major health care decisions.

Genome 98

Genome Genomics Scientist Genetics 98

pharmaphorum

NOVEMBER 23, 2021

Genomics England, the Department of Health and Social Care’s genome-sequencing hub, has this year announced that support for whole genome sequencing (WGS) has reached a level at which its national rollout on the NHS may someday become a reality. Only when genomic databases are diverse can we ensure that we all benefit equally.

Genomics 116

Genomics Genome Genetics Doctor 116

Drug Discovery Today

OCTOBER 27, 2022

The country now hosts the EMBL Partnership Institute for Genome Editing Technologies at the Vilnius University Life Sciences Center aiming to advance gene editing technologies. Six international research groups work at the EMBL Partnership Institute in Vilnius, each tackling a different facet of gene editing. One of them is the Jones!Lab,

Genomics 85

Genomics Genome Gene Editing Life Science 85

Medical Xpress

MARCH 13, 2023

New research in the March 2023 issue of JNCCN—Journal of the National Comprehensive Cancer Network highlights how the lack of genomic research for people with African ancestry, particularly those from the Sub-Saharan region, is hampering efforts to reduce disparities for people with cancer.

Genomics 75

Genomics Genome Research Genetics 75

Outsourcing Pharma

APRIL 19, 2021

One Healthâs FidoCure is using genomics and AI technology to develop precision oncological treatments, and the work is benefiting human cancer research.

Research 114

Research Genomics Genome Development 114

Scienmag

APRIL 13, 2022

New research from the University of New Hampshire examines coral reef ecosystems with a novel approach to understanding the complex evolution of sponges and the microbes that live […]. DURHAM, N.H.—Sponges

Genomics 89

Genomics Genome Research 89

Medical Xpress

NOVEMBER 23, 2022

Cancer research has significantly improved in recent years, primarily due to next-generation sequencing (NGS) technology. Consequently, an enormous amount of genomic and transcriptomic data has been generated. In most cases, the data needed for research goals are used, and unwanted reads are discarded.

Research 97

Research Genomics Genome Containment 97